Date of event
Tuesday, April 28, 2020 - 12:00 pm -
Tuesday, April 28, 2020 - 1:00 pm
Continuing Education Credits
None
Add to Calendar 2020-04-28 12:00:00 2020-04-28 13:00:00 Webinar: Chronic Hepatitis C 101 – The Basics As chronic hepatitis C infection therapy moves outside the realm of specialty care, more providers want to be well-versed in both identifying patients and treating them appropriately. This webinar is designed for the HCV-treating novice. Complimentary registration. AASLD alonzo.tolver@boldrstrategy.com America/New_York public

Content Contributor

Hepatitis C SIG

Presenter(s)

Lisa Catalli, MSN, NP-BC
Natarajan Ravendhran, MD, MBA, AGAF, FACG, FAASLD

Moderator / Presenter

Brian L. Pearlman, MD, FAASLD

Details

As chronic hepatitis C infection therapy moves outside the realm of specialty care, more providers want to be well-versed in both identifying patients and treating them appropriately. This webinar is designed for the HCV-treating novice.

Presenter Bios

Lisa Catalli, MSN, NP-BC

Lisa Catalli is a Nurse Practitioner at the University of California, San Francisco’s Viral Hepatitis Center and Liver Transplant Clinic. She earned her Master’s Degree from UCSF School of Nursing in 1995 and has been working in the field of Hepatology since 2010. She has been treating HCV since the dawn of direct-acting antiviral therapy, and served as a co-investigator in several multi-center clinical trials. Her expertise in HCV treatment has led to multiple educational and leadership activities in HCV elimination. She has worked to disseminate knowledge about HCV through mentoring students and didactic presentations and workshops. She is a key clinical faculty in the UCSF Project ECHO program which uses multi-point video conferencing to build knowledge-sharing networks with community providers to build the capacity for care of HCV patients throughout California.

She is also part of an interdisciplinary team to improve access and linkage to HCV care through a creative, innovative model of mobile liver care clinic (UCSF DeLiver Care) that is co-localized at syringe exchange/medically assisted treatment centers for vulnerable populations. She has been a Hepatology Associates member of AASLD for 10 years with leadership roles in the HCV SIG and the Hepatology Associates Committee, serving on committees for the planning of AASLD educational programs, moderating educational sessions, and selecting NP/PA fellowship awards.

Photo of Lisa Catalli

Natarajan Ravendhran, MD, MBA, AGAF, FACG, FAASLD

Dr. Ravendhran is a hepatologist in Baltimore, Maryland. He is trained in hepatology by Dr. Schiff at University of Miami. He is board-certified in gastroenterology and transplant hepatology. He is a medical director for the research department in Digestive Disease Associates in Baltimore. He holds faculty position at Johns Hopkins University as a clinical assistant professor in the department of medicine. He is a Fellow of American Association for Study of Liver Diseases.

He is actively involved in clinical trials, teaching and having a busy clinical practice. He has conducted more than 100 clinical trials in hepatology regarding chronic hepatitis C treatment, hepatitis B treatment and currently involved in many clinical trials with non-alcoholic fatty liver disease. He has published in Journal of Hepatology, Journal of American College of Gastroenterology, and New England Journal of Medicine.

Dr. Natarajan Ravendhran

Moderator / Presenter Bio

Brian L. Pearlman, MD, FAASLD

Brian L. Pearlman, MD is Medical Director for Wellstar Atlanta Medical Center’s Center for Hepatitis C in Atlanta Georgia. He is also Professor of Medicine at the Medical College of Georgia and Professor of Medicine at Emory School of Medicine. Dr. Pearlman completed his medical degree at the University of Miami, Florida and his post-graduate training included both Diagnostic Radiology at University of Texas-Southwestern and Internal Medicine at Baylor University-Dallas, Texas.

Dr. Pearlman is Faculty for the American College of Physicians (FACP), Fellow of the American Association for the Study of Liver Diseases (FAASLD), and members of the American Academy of HIV Medicine, and the American Gastroenterological Association. He sat on the Board of Directors for The American Liver Foundation’s Southeast Chapter. Dr. Pearlman is widely published in leading journals such as The Lancet, Gastroenterology, HEPATOLOGY, The American Journal of Gastroenterology, The Lancet Infectious Disease, Clinical Infectious Diseases and The American Journal of Medicine.

Dr. Pearlman is active in both patient care and in teaching physicians. He has been the recipient of numerous teaching awards, and also an active investigator in multiple hepatitis C-related trials, some of which are in collaboration with the CDC’s Division of Viral Hepatitis.

Dr. Brian Pearlman